A Phase III Trial of Ifosfamide with or without Cisplatin in Carcinosarcoma of the Uterus: A Gynecologic Oncology Group Study

Author： Sutton G.   Brunetto V.L.   Kilgore L.   Soper J.T.   McGehee R.   Olt G.   Lentz S.S.   Sorosky J.   Hsiu J.-G.  

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.79, Iss.2, 2000-11, pp. : 147-153

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a gynecologic oncology group study

By  

The Women's Oncology Review, Vol. 4, Iss. 4, 2004-12 ,pp. : 287-289

Informa Healthcare

Access to resources Recommend Favorite

Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study

By  

The Women's Oncology Review, Vol. 4, Iss. 3, 2004-09 ,pp. : 205-207

Informa Healthcare

Access to resources Recommend Favorite

Phase II Trial of Paclitaxel in Leiomyosarcoma of the Uterus: A Gynecologic Oncology Group Study

By Sutton G.   Blessing J.A.   Ball H.  

Gynecologic Oncology, Vol. 74, Iss. 3, 1999-09 ,pp. : 346-349

Elsevier

Access to resources Recommend Favorite

Phase II Trial of Etoposide in Leiomyosarcoma of the Uterus: A Gynecologic Oncology Group Study

By Thigpen T.   Blessing J.A.   Yordan E.   Valea F.   Vaccarello L.  

Gynecologic Oncology, Vol. 63, Iss. 1, 1996-10 ,pp. : 120-122

Academic Press

Access to resources Recommend Favorite

Paclitaxel in the Treatment of Carcinosarcoma of the Uterus: A Gynecologic Oncology Group Study

By Curtin J.P.   Blessing J.A.   Soper J.T.   DeGeest K.  

Gynecologic Oncology, Vol. 83, Iss. 2, 2001-11 ,pp. : 268-270

Elsevier

Access to resources Recommend Favorite